DNTH vs ORCL · rev $6.2M vs P/E 31, rev $67.36B
Dianthus Therapeutics Inc. (DNTH) versus Oracle Corporation (ORCL) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Safra Catz.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. Revenue was up 17.3% from 2025-05-31 to 2026-05-31. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
DNTH currently screens at market cap $4.40B. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Not investment advice. Open the DNTH and ORCL stock pages for the full models.
Not investment advice.